NMC Health Plc Notice of Half Year Results (3350U)

TIDMNMC

RNS Number : 3350U

NMC Health Plc

11 July 2018

NMC Health plc to Report Half Year Results on 20 August 2018

London, 11 July 2018: NMC Health plc (the "Company") will report its half year financial results (for the six months to 30 June 2018) on Monday, 20 August 2018.

The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.

Contacts

 
 NMC 
 Prasanth Manghat, Chief Executive 
  Officer 
  Prashanth Shenoy, Chief Financial      +971 (0)50 522 5648 
  Officer                                 +971 (0)56 329 0545 
  Asjad Yahya, Investor Relations         +971 (0)56 219 0975 
 
 Media 
 FTI Consulting, London 
 Brett Pollard / Mo Noonan / Victoria 
  Foster-Mitchell                        +44 (0)20 3727 1000 
 
 FTI Consulting, Gulf 
 Shane Dolan                             +971 (0)4 437 2100

About NMC Health

The NMC group (the "Group") is the leading United Arab Emirates private healthcare operator with an international network of hospitals and operations. The Group currently operates or manages over 150 assets across 13 countries. NMC is also ranked as one of the top 3 in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has 35% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. The enlarged company received over 5.7 million patients in 2017. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.6 billion for the year ended 31 December 2017.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index and MSCI Global Standard Index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORUASARWSABAAR

(END) Dow Jones Newswires

July 11, 2018 07:47 ET (11:47 GMT)

Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024